期刊
CANCER BIOLOGY & MEDICINE
卷 16, 期 4, 页码 647-654出版社
CHINA ANTI-CANCER ASSOC
DOI: 10.20892/j.issn.2095-3941.2019.0187
关键词
Natural killer cell; immunotherapy; adoptive cell transfer; genetic modification
资金
- Chinese Academy of Sciences [XDB29030201, XBD29030202]
- Ministry of Science and Technology of China [2016YFC1303503]
- National Natural Science Foundation of China [81788101, 81671558, 31571440, 81821001, 91542000]
- Major Projects of Science and Technology in Anhui Province [17030801024]
- Fundamental Research Funds for the Central Universities [YD2070002004]
Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions and characteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes the developments of recent years in cell sources, genetic modification, manufacturing systems, clinical programs, and outcomes. Future prospects and challenges in NK cell immunotherapy are also discussed, including off-the-shelf NK cell exploitation, automatic and closed manufacturing systems, cryopreservation, and therapies involving regulatory checkpoints.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据